Benzodiazepines are commonly prescribed to pediatric patients despite a narrow range of approved indications.1 Like opioids, benzodiazepines are subject to prescription drug misuse and have been associated with increased risk of opioid overdose and opioid-related mortality in adolescents and young adults.2-4 Because limited information is available on the use of benzodiazepines in these age groups, we examined trends in benzodiazepine prescriptions dispensed during a 12-year period, including potential treatment indications and concurrent use with opioids.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Toce MS, Michelson KA, Hudgins JD, Olson KL, Bourgeois FT. Trends in Benzodiazepine Prescribing for US Adolescents and Young Adults From 2008 to 2019. JAMA Pediatr. 2022;176(3):312–313. doi:10.1001/jamapediatrics.2021.5122
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.